Informações:
Falhas:
ID
14566
Descrição
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01835288
Link
https://clinicaltrials.gov/show/NCT01835288
Palavras-chave
Versões (1)
- 21/04/2016 21/04/2016 -
Transferido a
21 de abril de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01835288
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01835288
- StudyEvent: Eligibility
Similar models
Eligibility Adult Acute Megakaryoblastic Leukemia (M7) NCT01835288
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
aml
Item
aml, any french- american- british (fab) subtype except m3, with confirmed mutation in the npm1 gene
boolean
C0023467 (UMLS CUI [1])
relapsed and/or refractory aml
Item
relapsed and/or refractory aml from any duration of complete remission (cr); any number of prior therapies allowed
boolean
C2367456 (UMLS CUI [1])
eastern cooperative oncology group (ecog) performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2, life expectancy > 3 months
boolean
C1520224 (UMLS CUI [1])
serum creatinine
Item
serum creatinine =< 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
bilirubin
Item
bilirubin =< 2.0 mg/dl
boolean
C1278039 (UMLS CUI [1])
alanine aminotransferase
Item
alanine aminotransferase (alt)/aspartate aminotransferase (ast) =< 3 x upper limit of normal (uln)
boolean
C0201836 (UMLS CUI [1])
informed consent
Item
ability to understand and the willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
pregnant or breast-feeding
Item
pregnant or breast-feeding women will not be entered on this study due to risks of fetal and teratogenic adverse events as seen in animal/human studies; pregnancy tests must be obtained in women; sexually active males or females may not participate unless they have agreed to use an effective contraceptive method
boolean
C3242212 (UMLS CUI [1])
investigational drug
Item
patients who are currently receiving another investigational drug
boolean
C0013230 (UMLS CUI [1])
anti-cancer agents
Item
patients who are currently receiving other anti-cancer agents
boolean
C0003392 (UMLS CUI [1])
infection
Item
uncontrolled systemic fungal, bacterial, viral, or other infection (defined as exhibiting ongoing signs/symptoms related to the infection and without improvement, despite appropriate antibiotics or other treatment)
boolean
C3714514 (UMLS CUI [1])
hypersensitivity to arsenic trioxide
Item
known hypersensitivity to arsenic trioxide
boolean
C0020517 (UMLS CUI [1,1])
C0052416 (UMLS CUI [1,2])
C0052416 (UMLS CUI [1,2])